Literature DB >> 27719438

The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.

Noah W Sweat1, Larry W Bates2, Peter S Hendricks3.   

Abstract

Developing methods for improving creativity is of broad interest. Classic psychedelics may enhance creativity; however, the underlying mechanisms of action are unknown. This study was designed to assess whether a relationship exists between naturalistic classic psychedelic use and heightened creative problem-solving ability and if so, whether this is mediated by lifetime mystical experience. Participants (N = 68) completed a survey battery assessing lifetime mystical experience and circumstances surrounding the most memorable experience. They were then administered a functional fixedness task in which faster completion times indicate greater creative problem-solving ability. Participants reporting classic psychedelic use concurrent with mystical experience (n = 11) exhibited significantly faster times on the functional fixedness task (Cohen's d = -.87; large effect) and significantly greater lifetime mystical experience (Cohen's d = .93; large effect) than participants not reporting classic psychedelic use concurrent with mystical experience. However, lifetime mystical experience was unrelated to completion times on the functional fixedness task (standardized β = -.06), and was therefore not a significant mediator. Classic psychedelic use may increase creativity independent of its effects on mystical experience. Maximizing the likelihood of mystical experience may need not be a goal of psychedelic interventions designed to boost creativity.

Entities:  

Keywords:  Creativity; hallucinogen; mystical experience; problem solving; psilocybin; psychedelic

Mesh:

Substances:

Year:  2016        PMID: 27719438     DOI: 10.1080/02791072.2016.1234090

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  6 in total

1.  Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation.

Authors:  Rainer Kraehenmann; Dan Pokorny; Leonie Vollenweider; Katrin H Preller; Thomas Pokorny; Erich Seifritz; Franz X Vollenweider
Journal:  Psychopharmacology (Berl)       Date:  2017-04-07       Impact factor: 4.530

Review 2.  Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.

Authors:  Rainer Kraehenmann
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 3.  Unifying Theories of Psychedelic Drug Effects.

Authors:  Link R Swanson
Journal:  Front Pharmacol       Date:  2018-03-02       Impact factor: 5.810

4.  Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.

Authors:  Martin Andersson; Anette Kjellgren
Journal:  Harm Reduct J       Date:  2019-11-28

5.  Powerful substances in tiny amounts: An interview study of psychedelic microdosing.

Authors:  Petter Grahl Johnstad
Journal:  Nordisk Alkohol Nark       Date:  2018-02-15

6.  Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?

Authors:  Rita Kočárová; Jiří Horáček; Robin Carhart-Harris
Journal:  Front Psychiatry       Date:  2021-07-19       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.